Literature DB >> 29976741

Development of angiotensin II (1-7) analog as an oral therapeutic for the treatment of chemotherapy-induced myelosuppression.

Kevin Gaffney1,2, Michael Weinberg3, Maira Soto4,2, Stan Louie3, Kathleen Rodgers4,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29976741      PMCID： PMC6269317          DOI： 10.3324/haematol.2018.193771

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Angiotensin-(1-7) synergizes with colony-stimulating factors in hematopoietic recovery.

Authors:  Kathleen E Rodgers; Theresa B Espinoza; Norma Roda; Christopher J Meeks; Gere S diZerega
Journal:  Cancer Chemother Pharmacol       Date:  2013-10-05       Impact factor: 3.333

2.  Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer.

Authors:  Kathleen E Rodgers; Jamie Oliver; Gere S diZerega
Journal:  Cancer Chemother Pharmacol       Date:  2005-08-12       Impact factor: 3.333

3.  Estimation of cyclodextrin affinity to steroids.

Authors:  S M Khomutov; I A Sidorov; D V Dovbnya; M V Donova
Journal:  J Pharm Pharmacol       Date:  2002-05       Impact factor: 3.765

4.  Model-based approach to early predict prolonged high grade neutropenia in carboplatin-treated patients and guide G-CSF prophylactic treatment.

Authors:  Mélanie L Pastor; Céline M Laffont; Laurence Gladieff; Etienne Chatelut; Didier Concordet
Journal:  Pharm Res       Date:  2014-09-04       Impact factor: 4.200

5.  Angiotensin II Regulation of Proliferation, Differentiation, and Engraftment of Hematopoietic Stem Cells.

Authors:  Seungbum Kim; Michael Zingler; Jeffrey K Harrison; Edward W Scott; Christopher R Cogle; Defang Luo; Mohan K Raizada
Journal:  Hypertension       Date:  2016-01-18       Impact factor: 10.190

6.  Effect of angiotensin II on hematopoietic progenitor cell proliferation.

Authors:  K E Rodgers; S Xiong; R Steer; G S diZerega
Journal:  Stem Cells       Date:  2000       Impact factor: 6.277

Review 7.  Managing thrombocytopenia associated with cancer chemotherapy.

Authors:  David J Kuter
Journal:  Oncology (Williston Park)       Date:  2015-04       Impact factor: 2.990

8.  Pharmacodynamic stimulation of thrombogenesis by angiotensin (1-7) in recurrent ovarian cancer patients receiving gemcitabine and platinum-based chemotherapy.

Authors:  Huyen Pham; Benjamin M Schwartz; James E Delmore; Eddie Reed; Scott Cruickshank; Leanne Drummond; Kathleen E Rodgers; Kainoa J Peterson; Gere S diZerega
Journal:  Cancer Chemother Pharmacol       Date:  2013-01-31       Impact factor: 3.333

Review 9.  The bone marrow niche for haematopoietic stem cells.

Authors:  Sean J Morrison; David T Scadden
Journal:  Nature       Date:  2014-01-16       Impact factor: 49.962

Review 10.  Contribution of the Local RAS to Hematopoietic Function: A Novel Therapeutic Target.

Authors:  Kathleen E Rodgers; Gere S Dizerega
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-23       Impact factor: 5.555
View more
  1 in total

Review 1.  Glycopeptide drugs: A pharmacological dimension between "Small Molecules" and "Biologics".

Authors:  Christopher R Apostol; Meredith Hay; Robin Polt
Journal:  Peptides       Date:  2020-07-13       Impact factor: 3.750
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.